Compounds > 2-(n,n-dipropyl)amino-5,6-dihydroxytetralin
Page last updated: 2024-09-03

2-(n,n-dipropyl)amino-5,6-dihydroxytetralin and ergoline

2-(n,n-dipropyl)amino-5,6-dihydroxytetralin has been researched along with ergoline in 1 studies

Compound Research Comparison

Studies
(2-(n,n-dipropyl)amino-5,6-dihydroxytetralin)		Trials
(2-(n,n-dipropyl)amino-5,6-dihydroxytetralin)		Recent Studies (post-2010)
(2-(n,n-dipropyl)amino-5,6-dihydroxytetralin)		Studies
(ergoline)		Trials
(ergoline)		Recent Studies (post-2010) (ergoline)
37004,324381441

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arnerić, SP; Chow, SA; Fischer, LJ; Long, JP1

Other Studies

1 other study(ies) available for 2-(n,n-dipropyl)amino-5,6-dihydroxytetralin and ergoline

ArticleYear
Dopamine analog-induced hyperglycemia in rats: involvement of the adrenal medulla and the endocrine pancreas.
    The Journal of pharmacology and experimental therapeutics, 1984, Volume: 228, Issue:3

    Topics: Adrenal Medulla; Animals; Apomorphine; Blood Glucose; Bromocriptine; Dextroamphetamine; Dihydroxyphenylalanine; Dopamine; Ergolines; Indans; Insulin; Islets of Langerhans; Male; Pergolide; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Dopamine; Tetrahydronaphthalenes

1984